☰
×
Top 20
Insights
Insight+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
App
Advertisement
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Pfizer
Pfizer Reports NDA Submission of Paxlovid to the US FDA for the Treatment of COVID-19
July 1, 2022
Disease of the Month: Vitiligo Disease | PharmaShots
June 25, 2022
Pfizer Reports Updated Results of Paxlovid (nirmatrelvir and ritonavir) in the P-II/III (EPIC-SR) Trial for the Treatment of COVID...
June 15, 2022
Pfizer’s Ervogastat + Clesacostat Receives the US FDA’s Fast Track Designation for the Treatment of Non-Alcoholic Steatohepatitis
May 27, 2022
Pfizer and BioNTech Report EUA Expansion for Booster Dose of COVID-19 Vaccine in Children Aged 5 Through 11 Years
May 18, 2022
Pfizer Files Lawsuit to Halt Sales of Brenzys (biosimilar, etanercept) in Australia
May 16, 2022
Load more...
No more records!